- Home
- OBIO vs XPER Comparison
OBIO vs XPER Comparison
Compare OBIO & XPER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OBIO | XPER |
|---|---|---|
| Founded | 2017 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 237.2M | 276.6M |
| IPO Year | N/A | 2003 |
Fundamental Metrics
Financial Performance| Metric | OBIO | XPER |
|---|---|---|
| Price | $3.95 | $5.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $14.25 | $11.00 |
| AVG Volume (30 Days) | 219.1K | ★ 398.9K |
| Earning Date | 11-10-2025 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.15 |
| Revenue | $2,818,000.00 | ★ $453,960,000.00 |
| Revenue This Year | $36.66 | N/A |
| Revenue Next Year | $2.30 | $5.69 |
| P/E Ratio | ★ N/A | $35.08 |
| Revenue Growth | ★ 6.46 | N/A |
| 52 Week Low | $2.20 | $5.09 |
| 52 Week High | $6.02 | $9.59 |
Technical Indicators
Market Signals| Indicator | OBIO | XPER |
|---|---|---|
| Relative Strength Index (RSI) | 45.48 | 34.48 |
| Support Level | $3.46 | $5.09 |
| Resistance Level | $4.24 | $5.80 |
| Average True Range (ATR) | 0.31 | 0.22 |
| MACD | -0.02 | -0.09 |
| Stochastic Oscillator | 45.70 | 14.69 |
Price Performance
Historical ComparisonAbout OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About XPER Xperi Inc.
Xperi Inc is a consumer and entertainment technology company. Its offering comprises a portfolio of software and services. The company creates extraordinary experiences at home and on the go for millions of consumers around the world, enabling audiences to connect with content in a more intelligent, immersive, and personal way. Its business is divided into four categories based on the products delivered and customers served: Pay-TV, Consumer Electronics, Connected Car, and Platform Solutions. It generates the majority of its revenue from the Consumer Electronics segment. Its also have sales in Japan, Europe and Middle East, China, South Korea, Latin America, and Others.